Jonas Eriksson

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 12

Top Venues

EJNMMI radiopharmacy and chemistry

Biomedicines

Journal of nuclear medicine : official publication, Society of Nuclear Medicine

Journal of labelled compounds & radiopharmaceuticals

Uppsala Universitet (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

Uppsala Universitet

Sweden

PHD

Publications

Eva Schlein, Johanna Rokka, Luke R Odell, Sara Lopes van den Broek, Matthias M Herth, Umberto M Battisti, Stina Syvänen, Dag Sehlin, Jonas Eriksson
Synthesis and evaluation of fluorine-18 labelled tetrazines as pre-targeting imaging agents for PET. EJNMMI radiopharmacy and chemistry 9 (1) (2024)
Eva Schlein, Johanna Rokka, Luke R Odell, Sara Lopes van den Broek, Matthias M Herth, Umberto M Battisti, Stina Syvänen, Dag Sehlin, Jonas Eriksson
Synthesis and evaluation of fluorine-18 labelled tetrazines as pre-targeting imaging agents for PET. EJNMMI radiopharmacy and chemistry 9 (1) (2024)
Eva Schlein, Johanna Rokka, Luke R Odell, Sara Lopes van den Broek, Matthias M Herth, Umberto M Battisti, Stina Syvänen, Dag Sehlin, Jonas Eriksson
Synthesis and evaluation of fluorine-18 labelled tetrazines as pre-targeting imaging agents for PET. EJNMMI radiopharmacy and chemistry 9 (1) (2024)
Sahar Roshanbin, Ulrika H Julku, Mengfei Xiong, Jonas Eriksson, Eliezer Masliah, Greta Hultqvist, Joakim Bergström, Martin Ingelsson, Stina Syvänen, Dag Sehlin
Reduction of αSYN Pathology in a Mouse Model of PD Using a Brain-Penetrating Bispecific Antibody. Pharmaceutics 14 (7) (2022)
Eva Schlein, Stina Syvanen, Johanna Rokka, Tobias Gustavsson, Raffaella Rossin, Marc S Robillard, Jonas Eriksson, Dag Sehlin
Functionalization of Radiolabeled Antibodies to Enhance Peripheral Clearance for High Contrast Brain Imaging. Molecular pharmaceutics 19 (11) (2022)
Johanna Rokka, Patrik Nordeman, Sara Roslin, Jonas Eriksson
A comparative study on Suzuki-type 11 C-methylation of aromatic organoboranes performed in two reaction media. Journal of labelled compounds & radiopharmaceuticals 64 (11) (2021)
Silvio R Meier, Dag Sehlin, Sahar Roshanbin, Victoria Lim Falk, Takashi Saito, Takaomi C Saido, Ulf Neumann, Johanna Rokka, Jonas Eriksson, Stina Syvanen
11C-PIB and 124I-antibody PET provide differing estimates of brain amyloid-beta after therapeutic intervention. Journal of nuclear medicine : official publication, Society of Nuclear Medicine (2021)
Pierre Cheung, Bo Zhang, Emmi Puuvuori, Sergio Estrada, Mohammad A Amin, Sofie Ye, Olle Korsgren, Luke R Odell, Jonas Eriksson, Olof Eriksson
PET Imaging of GPR44 by Antagonist [11C]MK-7246 in Pigs. Biomedicines 9 (4) (2021)
Stina Syvanen, Xiaotian T Fang, Rebecca Faresjö, Johanna Rokka, Lars Lannfelt, Dag E Olberg, Jonas Eriksson, Dag Sehlin
Fluorine-18-Labeled Antibody Ligands for PET Imaging of Amyloid-β in Brain. ACS chemical neuroscience 11 (24) (2020)
My Jonasson, Patrik Nordeman, Jonas Eriksson, Helena Wilking, Johan Wikström, Kayo Takahashi, Takashi Niwa, Takamitsu Hosoya, Yasuyoshi Watanabe, Gunnar Antoni, Inger Sundström Poromaa, Mark Lubberink, Erika Comasco
Quantification of aromatase binding in the female human brain using [11 C]cetrozole positron emission tomography. Journal of neuroscience research 98 (11) (2020)
Johanna Rokka, Eva Schlein, Jonas Eriksson
Improved synthesis of SV2A targeting radiotracer [11C]UCB-J. EJNMMI radiopharmacy and chemistry 4 (1) (2019)
Sara Roslin, Peter Brandt, Patrik Nordeman, Mats Larhed, Luke R Odell, Jonas Eriksson
Synthesis of 11C-Labelled Ureas by Palladium(II)-Mediated Oxidative Carbonylation. Molecules (Basel, Switzerland) 22 (10) (2017)

Jonas Eriksson.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Jonas Eriksson